Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|July 4, 2006
Glucocerebroside ameliorates the metabolic syndrome in OB/OB miceMaya Margalit, Zvi Shalev, Orit Pappo, et al.
The American Journal of Gastroenterology|March 18, 2006
A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approachMaya Margalit, Eran Israeli, Oren Shibolet, et al.
Journal of Inherited Metabolic Disease|January 6, 2010
Disease severity in sibling pairs with type 1 Gaucher diseaseDeborah Elstein, Ayelet Gellman, Gheona Altarescu, et al.
The Journal of Pathology|November 2, 2005
Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levelsEran Elinav, Orit Pappo, Miriam Sklair-Levy, et al.
International Journal of MS Care|March 1, 2017
Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO TrialsPer Soelberg Sørensen, Giancarlo Comi, Timothy L Vollmer, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 25, 2005
Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytesMaya Margalit, Samir Abu Gazala, Samir Abu Ghazala, et al.
Gut|February 28, 2024
MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASHRohit Loomba, Maral Amangurbanova, Ricki Bettencourt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2026
Clinical utility of a 50% and 30% decline in MRI-PDFF in predicting fibrosis improvement in metabolic dysfunction-associated steatohepatitisRohit Loomba, Peter Chen-Yang Nikhil Daniel, Youxin Wang, et al.
Hepatology (Baltimore, Md.)|May 13, 2025
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsyRohit Loomba, Peter Chen-Yang Nikhil Daniel, Maral Amangurbanova, et al.
Alimentary Pharmacology & Therapeutics|September 18, 2023
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitisNaim Alkhouri, Donald Lazas, Rohit Loomba, et al.
Pageof 3